Treatment & Management
The research led by this Think Tank aims to optimize treatment strategies for people living and aging with HIV and STBBIs to promote long-term engagement in care, reduce comorbidities, and improve quality of life.
-
CTNPT 019: Improving outcomes with Metformin
Can metformin prevent the progression of liver fibrosis in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance?
-
CTNPT 024: Non-alcoholic steatohepatitis in HIV mono-infection
Use of non-invasive methods for diagnosis of non-alcoholic steatohepatitis (NASH) in HIV patients and therapeutic use of vitamin E
-
CTN 283: the I-Score Study
The development and validation of a patient-reported measure of antiretroviral therapy’s interference with life: a clinical patient-management tool for healthcare providers
-
-
CTNPT 008: HIV quit smoking pilot study
Counselling programme in combination with nicotine replacement therapy
-
CTNPT 026: Neuroimaging as a biomarker for cognitive training in HAND
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
-
CTNPT 023: the NOMAD Study
A pilot study of a novel, mRNA-based assay for the diagnosis of anal HPV infection HIV-positive MSM
-
CTN 290: HIV and Sleep
Efficacy potential of an internet-based sleep program to improve sleep quality in people with HIV
-
CTN 299: BEING-W
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
-
CTN 292B: Treatment of high-grade anal dysplasia in HIV+ MSM
A randomized controlled, open-label trial examining the efficacy, safety, and tolerability of ablative therapies for high-grade anal dysplasia versus observation alone in HIV-positive men who have sex with men (MSM) – part of HPV-SAVE study.
-
CTNPT 029: Psychosocial intervention for older HIV+ adults with HAND
Development of a psychosocial intervention trial with the goal to improve older adults’ ability to cope with HIV-Associated Neurocognitive Disorder (HAND)
-
CTNPT 028: Cannabinoids in HIV-infected individuals on effective ART
Safety, tolerability, and effect on immune function of cannabinoids